Formulation development of dual-compartment topical inserts combining tenofovir alafenamide and elvitegravir for flexible on-demand HIV prevention Article

sustainable development goals

publication date

  • December 6, 2024

webpage

published in

keywords

  • Antiretroviral
  • HIV pre-exposure and post-exposure prophylaxis
  • TAF/EVG insert clinical development
  • Topical formulation
  • Vaginal and rectal drug delivery

start page

  • 842

end page

  • 854

volume

  • 377